{
    "2021-03-18": [
        [
            {
                "time": "",
                "original_text": "抗肿瘍新药行业专题系列2：血癌篇：三大靶向新品层出 CAR-T疗法蓄势待发",
                "features": {
                    "keywords": [
                        "抗肿瘤",
                        "新药",
                        "血癌",
                        "靶向治疗",
                        "CAR-T疗法"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复星医药子公司YP01001胶囊获批开展针对晚期实体瘤的临床试验",
                "features": {
                    "keywords": [
                        "复星医药",
                        "YP01001胶囊",
                        "临床试验",
                        "晚期实体瘤"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}